

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.05037983 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05037983 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84254487 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.67782111 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41163050 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.41163050 |
| 7 | neutrophil activation (GO:0042119) | 4.14117182 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 3.97583096 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96841740 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.94695343 |
| 11 | granulocyte activation (GO:0036230) | 3.92786858 |
| 12 | detection of other organism (GO:0098543) | 3.89003826 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.88884685 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.78566858 |
| 15 | detection of bacterium (GO:0016045) | 3.70674554 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66340650 |
| 17 | regulation of cholesterol storage (GO:0010885) | 3.66210996 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.58238505 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.57739260 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53504079 |
| 21 | response to type I interferon (GO:0034340) | 3.48219080 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.46566890 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.46566890 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45564577 |
| 25 | detection of external biotic stimulus (GO:0098581) | 3.44208677 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39546677 |
| 27 | microglial cell activation (GO:0001774) | 3.39380227 |
| 28 | regulation of platelet aggregation (GO:0090330) | 3.38127502 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 3.34856367 |
| 30 | cellular extravasation (GO:0045123) | 3.28808278 |
| 31 | positive regulation of mast cell activation (GO:0033005) | 3.27373522 |
| 32 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.25075940 |
| 33 | response to interferon-alpha (GO:0035455) | 3.24436612 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.24177543 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.22905329 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.22905329 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.22905329 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.22905329 |
| 39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.22905329 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.22905329 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.22242139 |
| 42 | plasma lipoprotein particle clearance (GO:0034381) | 3.20472974 |
| 43 | protein carboxylation (GO:0018214) | 3.19774490 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.19774490 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17647612 |
| 46 | valine metabolic process (GO:0006573) | 3.17112697 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.16726878 |
| 48 | response to host immune response (GO:0052572) | 3.16726878 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.15427490 |
| 50 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.14400838 |
| 51 | daunorubicin metabolic process (GO:0044597) | 3.12577641 |
| 52 | polyketide metabolic process (GO:0030638) | 3.12577641 |
| 53 | doxorubicin metabolic process (GO:0044598) | 3.12577641 |
| 54 | response to interleukin-15 (GO:0070672) | 3.08984986 |
| 55 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08017071 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08017071 |
| 57 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06052931 |
| 58 | dendritic cell chemotaxis (GO:0002407) | 3.05210803 |
| 59 | regulation of regulatory T cell differentiation (GO:0045589) | 3.04888951 |
| 60 | germinal center formation (GO:0002467) | 3.03529927 |
| 61 | regulation of platelet activation (GO:0010543) | 3.03307049 |
| 62 | complement activation, alternative pathway (GO:0006957) | 3.00693780 |
| 63 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.99412157 |
| 64 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97586922 |
| 65 | negative regulation of lipid storage (GO:0010888) | 2.97427476 |
| 66 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96906404 |
| 67 | leukocyte degranulation (GO:0043299) | 2.96439991 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95679036 |
| 69 | positive regulation of type 2 immune response (GO:0002830) | 2.94013903 |
| 70 | detection of biotic stimulus (GO:0009595) | 2.93956673 |
| 71 | macrophage activation (GO:0042116) | 2.93848145 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.92171962 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.91888837 |
| 74 | phagocytosis, recognition (GO:0006910) | 2.91746037 |
| 75 | regulation of mast cell activation (GO:0033003) | 2.89969135 |
| 76 | sulfur amino acid catabolic process (GO:0000098) | 2.89426336 |
| 77 | response to host (GO:0075136) | 2.88051165 |
| 78 | response to host defenses (GO:0052200) | 2.88051165 |
| 79 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88051165 |
| 80 | regulation of sequestering of triglyceride (GO:0010889) | 2.87181701 |
| 81 | leukocyte aggregation (GO:0070486) | 2.87109599 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.85397976 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.85073988 |
| 84 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.85073988 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84868438 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84446055 |
| 87 | positive regulation of B cell differentiation (GO:0045579) | 2.82748785 |
| 88 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81479763 |
| 89 | response to peptidoglycan (GO:0032494) | 2.80905182 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.79333645 |
| 91 | dendritic cell migration (GO:0036336) | 2.77201155 |
| 92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76485697 |
| 93 | positive regulation of macrophage differentiation (GO:0045651) | 2.75643086 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 2.74988180 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 2.74924032 |
| 96 | reactive oxygen species biosynthetic process (GO:1903409) | 2.74301027 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74085959 |
| 98 | regulation of protein activation cascade (GO:2000257) | 2.72885920 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72508280 |
| 100 | regulation of leukocyte degranulation (GO:0043300) | 2.71862845 |
| 101 | negative regulation of innate immune response (GO:0045824) | 2.71529507 |
| 102 | thrombin receptor signaling pathway (GO:0070493) | 2.70952683 |
| 103 | defense response to protozoan (GO:0042832) | 2.70103386 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 2.69988199 |
| 105 | regulation of complement activation (GO:0030449) | 2.68748410 |
| 106 | T cell migration (GO:0072678) | 2.68622823 |
| 107 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.67326064 |
| 108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66832499 |
| 109 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66352500 |
| 110 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66352500 |
| 111 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.66178350 |
| 112 | cellular response to interferon-alpha (GO:0035457) | 2.65772534 |
| 113 | natural killer cell mediated immunity (GO:0002228) | 2.63872167 |
| 114 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.63872167 |
| 115 | myeloid leukocyte activation (GO:0002274) | 2.63433494 |
| 116 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63107550 |
| 117 | regulation of tolerance induction (GO:0002643) | 2.62704249 |
| 118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62053885 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61950320 |
| 120 | positive regulation of lipid storage (GO:0010884) | 2.61009307 |
| 121 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.60872489 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60375388 |
| 123 | cofactor catabolic process (GO:0051187) | 2.60152212 |
| 124 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58408701 |
| 125 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.58364713 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 2.58191715 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.57912688 |
| 128 | apoptotic cell clearance (GO:0043277) | 2.56150124 |
| 129 | phospholipid homeostasis (GO:0055091) | 2.55566804 |
| 130 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.54826205 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 2.53807026 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.51871396 |
| 133 | L-phenylalanine metabolic process (GO:0006558) | 2.50969797 |
| 134 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.50969797 |
| 135 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.50820851 |
| 136 | detection of molecule of bacterial origin (GO:0032490) | 2.50615792 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 2.50375048 |
| 138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.48681111 |
| 139 | L-phenylalanine catabolic process (GO:0006559) | 2.48681111 |
| 140 | phospholipid efflux (GO:0033700) | 2.47597111 |
| 141 | urea metabolic process (GO:0019627) | 2.45802826 |
| 142 | urea cycle (GO:0000050) | 2.45802826 |
| 143 | aromatic amino acid family catabolic process (GO:0009074) | 2.45092195 |
| 144 | negative regulation of viral genome replication (GO:0045071) | 2.43925894 |
| 145 | response to interferon-beta (GO:0035456) | 2.43522303 |
| 146 | cysteine metabolic process (GO:0006534) | 2.42247290 |
| 147 | indole-containing compound catabolic process (GO:0042436) | 2.41948816 |
| 148 | indolalkylamine catabolic process (GO:0046218) | 2.41948816 |
| 149 | tryptophan catabolic process (GO:0006569) | 2.41948816 |
| 150 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.41215393 |
| 151 | positive regulation of blood coagulation (GO:0030194) | 2.40924897 |
| 152 | positive regulation of hemostasis (GO:1900048) | 2.40924897 |
| 153 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.40754130 |
| 154 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.40604364 |
| 155 | B cell mediated immunity (GO:0019724) | 2.39638413 |
| 156 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.39435617 |
| 157 | respiratory burst (GO:0045730) | 2.38916396 |
| 158 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.36824066 |
| 159 | fatty acid transmembrane transport (GO:1902001) | 2.36602166 |
| 160 | cellular response to virus (GO:0098586) | 2.36568868 |
| 161 | epoxygenase P450 pathway (GO:0019373) | 2.36525661 |
| 162 | tryptophan metabolic process (GO:0006568) | 2.36219059 |
| 163 | positive regulation of coagulation (GO:0050820) | 2.34958871 |
| 164 | aldehyde catabolic process (GO:0046185) | 2.34873917 |
| 165 | T-helper 1 type immune response (GO:0042088) | 2.34291387 |
| 166 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34086198 |
| 167 | homocysteine metabolic process (GO:0050667) | 2.33665863 |
| 168 | kynurenine metabolic process (GO:0070189) | 2.33074649 |
| 169 | cytidine deamination (GO:0009972) | 2.32980130 |
| 170 | cytidine metabolic process (GO:0046087) | 2.32980130 |
| 171 | cytidine catabolic process (GO:0006216) | 2.32980130 |
| 172 | negative regulation of fibrinolysis (GO:0051918) | 2.32368879 |
| 173 | hormone catabolic process (GO:0042447) | 2.32274519 |
| 174 | primary alcohol catabolic process (GO:0034310) | 2.32074037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.50514102 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41889860 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.60898647 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.27533142 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.21986390 |
| 6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.80295836 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49045264 |
| 8 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.18993350 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93581046 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91199342 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85532362 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.76512509 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70832227 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.59468590 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58617871 |
| 16 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.56099701 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.45825898 |
| 18 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.31321815 |
| 19 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.20933564 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.19927440 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11242719 |
| 22 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02688985 |
| 23 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.99404373 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98594140 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93207759 |
| 26 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92666606 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89569023 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83721020 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82236389 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.82078938 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81600546 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75803944 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74997140 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.72617921 |
| 35 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.72556682 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.70574301 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68321440 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65779506 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63818307 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61670635 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58966065 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.52254663 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.52102142 |
| 44 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46029706 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44458841 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44299558 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40852957 |
| 48 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38864571 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37434669 |
| 50 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34100789 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.33700926 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30802666 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.28590864 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27346157 |
| 55 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26117095 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.24940543 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23619139 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21338561 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20388316 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20282396 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16489975 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16383083 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15541560 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13166549 |
| 65 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.11158687 |
| 66 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09614870 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08888316 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08326938 |
| 69 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08158328 |
| 70 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08158328 |
| 71 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08158328 |
| 72 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07553089 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06663224 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05387350 |
| 75 | * MYB_26560356_Chip-Seq_TH2_Human | 1.05316965 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.04831543 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03694935 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01974283 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01232483 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01022241 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00643493 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99668710 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98735299 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98267872 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97473842 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95941484 |
| 87 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95480088 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95440126 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95420817 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94997470 |
| 91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94715250 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94367840 |
| 93 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94202488 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94120774 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92805241 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92791331 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92611053 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91577023 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90992323 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90797797 |
| 101 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90182580 |
| 102 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90168988 |
| 103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89879412 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89103526 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88645781 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88444644 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88266766 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87579800 |
| 109 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87447176 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86915467 |
| 111 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85358151 |
| 112 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.85295991 |
| 113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84383476 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84114058 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83839029 |
| 116 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83671258 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82871293 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82582689 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82392378 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.81769344 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81740043 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81069313 |
| 123 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80968744 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80880773 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80676437 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 0.79998579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.10946755 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 2.93694953 |
| 3 | MP0005360_urolithiasis | 2.92203861 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.88736465 |
| 5 | MP0003724_increased_susceptibility_to | 2.86312264 |
| 6 | MP0003436_decreased_susceptibility_to | 2.65746879 |
| 7 | MP0006082_CNS_inflammation | 2.64045529 |
| 8 | MP0009785_altered_susceptibility_to | 2.59487001 |
| 9 | MP0002254_reproductive_system_inflammat | 2.56528968 |
| 10 | MP0009840_abnormal_foam_cell | 2.41644332 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.33767483 |
| 12 | MP0008004_abnormal_stomach_pH | 2.33064483 |
| 13 | MP0005365_abnormal_bile_salt | 2.14907810 |
| 14 | MP0005025_abnormal_response_to | 2.05336715 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02572721 |
| 16 | MP0000685_abnormal_immune_system | 2.00985583 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 1.97427691 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.96330053 |
| 19 | MP0002419_abnormal_innate_immunity | 1.90964565 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 1.90496571 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.90351306 |
| 22 | MP0003303_peritoneal_inflammation | 1.87470635 |
| 23 | MP0005387_immune_system_phenotype | 1.86364518 |
| 24 | MP0001790_abnormal_immune_system | 1.86364518 |
| 25 | MP0009764_decreased_sensitivity_to | 1.80619705 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.80592000 |
| 27 | MP0004510_myositis | 1.79412097 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.78435242 |
| 29 | MP0000343_altered_response_to | 1.77519768 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.70165108 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.68478690 |
| 32 | MP0003011_delayed_dark_adaptation | 1.64144164 |
| 33 | MP0001853_heart_inflammation | 1.60589975 |
| 34 | MP0003186_abnormal_redox_activity | 1.60554400 |
| 35 | MP0005671_abnormal_response_to | 1.58541125 |
| 36 | MP0002132_abnormal_respiratory_system | 1.58457734 |
| 37 | MP0008469_abnormal_protein_level | 1.57659362 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.56797004 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.56615981 |
| 40 | MP0003252_abnormal_bile_duct | 1.55177452 |
| 41 | MP0005451_abnormal_body_composition | 1.54566755 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.54445167 |
| 43 | MP0001800_abnormal_humoral_immune | 1.53467257 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.53019914 |
| 45 | MP0008260_abnormal_autophagy | 1.52101828 |
| 46 | MP0000609_abnormal_liver_physiology | 1.51155638 |
| 47 | MP0002723_abnormal_immune_serum | 1.49795055 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.48815752 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.45927207 |
| 50 | MP0004130_abnormal_muscle_cell | 1.42327681 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.40507675 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.39979660 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.36634493 |
| 54 | MP0005670_abnormal_white_adipose | 1.36003069 |
| 55 | MP0002722_abnormal_immune_system | 1.34291171 |
| 56 | MP0005083_abnormal_biliary_tract | 1.33212466 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.32437551 |
| 58 | MP0004947_skin_inflammation | 1.32112308 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.30917577 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.28677991 |
| 61 | MP0003866_abnormal_defecation | 1.27915908 |
| 62 | MP0001819_abnormal_immune_cell | 1.26071045 |
| 63 | MP0001851_eye_inflammation | 1.25128229 |
| 64 | MP0003448_altered_tumor_morphology | 1.23945935 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.23515867 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.23368235 |
| 67 | MP0003075_altered_response_to | 1.22114477 |
| 68 | MP0002405_respiratory_system_inflammati | 1.21778461 |
| 69 | MP0005332_abnormal_amino_acid | 1.21648538 |
| 70 | MP0003828_pulmonary_edema | 1.20137697 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.19756938 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.19719076 |
| 73 | MP0009763_increased_sensitivity_to | 1.17188109 |
| 74 | MP0004883_abnormal_blood_vessel | 1.16911399 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.16526775 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.16023371 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 1.13430169 |
| 78 | MP0005164_abnormal_response_to | 1.13208847 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.13123544 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.10189655 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09065172 |
| 82 | MP0000858_altered_metastatic_potential | 1.05669654 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.05319356 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 1.04596932 |
| 85 | MP0002998_abnormal_bone_remodeling | 1.04509577 |
| 86 | MP0000703_abnormal_thymus_morphology | 1.02127465 |
| 87 | MP0001663_abnormal_digestive_system | 1.01928743 |
| 88 | MP0000249_abnormal_blood_vessel | 1.01106417 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.96650882 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.95566843 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.95566843 |
| 92 | MP0005166_decreased_susceptibility_to | 0.94462131 |
| 93 | MP0000604_amyloidosis | 0.94006256 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.93830394 |
| 95 | MP0000598_abnormal_liver_morphology | 0.92630019 |
| 96 | MP0009115_abnormal_fat_cell | 0.92210411 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.92058662 |
| 98 | MP0000716_abnormal_immune_system | 0.91372468 |
| 99 | MP0002971_abnormal_brown_adipose | 0.90314568 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.90086994 |
| 101 | MP0003690_abnormal_glial_cell | 0.89464985 |
| 102 | MP0004381_abnormal_hair_follicle | 0.87769251 |
| 103 | MP0009278_abnormal_bone_marrow | 0.87455407 |
| 104 | MP0005310_abnormal_salivary_gland | 0.87404249 |
| 105 | MP0005023_abnormal_wound_healing | 0.86813984 |
| 106 | MP0002006_tumorigenesis | 0.86111262 |
| 107 | MP0008874_decreased_physiological_sensi | 0.85041282 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.84551648 |
| 109 | MP0003045_fibrosis | 0.84434935 |
| 110 | MP0000689_abnormal_spleen_morphology | 0.80990137 |
| 111 | MP0001958_emphysema | 0.80443503 |
| 112 | MP0003279_aneurysm | 0.80318367 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.80106638 |
| 114 | MP0003195_calcinosis | 0.79749102 |
| 115 | MP0002429_abnormal_blood_cell | 0.79065855 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.78559077 |
| 117 | MP0005390_skeleton_phenotype | 0.78207217 |
| 118 | MP0002398_abnormal_bone_marrow | 0.75813354 |
| 119 | MP0006054_spinal_hemorrhage | 0.75749679 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.75635189 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.74289579 |
| 122 | MP0003795_abnormal_bone_structure | 0.68118052 |
| 123 | MP0004808_abnormal_hematopoietic_stem | 0.67349217 |
| 124 | MP0003879_abnormal_hair_cell | 0.63624612 |
| 125 | MP0003091_abnormal_cell_migration | 0.63074560 |
| 126 | MP0005165_increased_susceptibility_to | 0.61994252 |
| 127 | MP0002933_joint_inflammation | 0.61955445 |
| 128 | MP0005535_abnormal_body_temperature | 0.61565030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 6.19064162 |
| 2 | Abnormal platelet volume (HP:0011876) | 4.74883733 |
| 3 | Menorrhagia (HP:0000132) | 4.70271363 |
| 4 | Increased mean platelet volume (HP:0011877) | 4.44849143 |
| 5 | Stomatitis (HP:0010280) | 4.36082555 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33051875 |
| 7 | Optic neuritis (HP:0100653) | 4.31999286 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.31999286 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.29873131 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.23627094 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.87396084 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.84274628 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.72453374 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53237878 |
| 15 | Obstructive lung disease (HP:0006536) | 3.53237878 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.50008868 |
| 17 | Complement deficiency (HP:0004431) | 3.39869207 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.37381801 |
| 19 | Xanthomatosis (HP:0000991) | 3.37178355 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.37113767 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.33804563 |
| 22 | Joint hemorrhage (HP:0005261) | 3.33656268 |
| 23 | Encephalitis (HP:0002383) | 3.30336955 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29524296 |
| 25 | Deep venous thrombosis (HP:0002625) | 3.22947646 |
| 26 | Myocardial infarction (HP:0001658) | 3.19105585 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 3.15611294 |
| 28 | Meningitis (HP:0001287) | 3.12798299 |
| 29 | Axonal loss (HP:0003447) | 3.11976650 |
| 30 | Impaired platelet aggregation (HP:0003540) | 3.11527793 |
| 31 | Abnormal platelet function (HP:0011869) | 3.11527793 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 3.07047184 |
| 33 | Arterial thrombosis (HP:0004420) | 2.93530874 |
| 34 | T lymphocytopenia (HP:0005403) | 2.90304620 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.89687051 |
| 36 | Keratoconjunctivitis (HP:0001096) | 2.87570998 |
| 37 | Orchitis (HP:0100796) | 2.85394589 |
| 38 | Myositis (HP:0100614) | 2.84197005 |
| 39 | Abnormality of complement system (HP:0005339) | 2.82710088 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82519209 |
| 41 | Chest pain (HP:0100749) | 2.81733966 |
| 42 | Abnormality of T cell number (HP:0011839) | 2.79837565 |
| 43 | Gingival bleeding (HP:0000225) | 2.79666581 |
| 44 | Nasal polyposis (HP:0100582) | 2.78337756 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75384878 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73597025 |
| 47 | Tetraparesis (HP:0002273) | 2.73111306 |
| 48 | Episodic fever (HP:0001954) | 2.72307896 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.71514362 |
| 50 | Intrahepatic cholestasis (HP:0001406) | 2.69078671 |
| 51 | Esophageal varix (HP:0002040) | 2.67781005 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.67323322 |
| 53 | Purpura (HP:0000979) | 2.66211232 |
| 54 | Amyloidosis (HP:0011034) | 2.64090251 |
| 55 | Hematochezia (HP:0002573) | 2.63954528 |
| 56 | Gingivitis (HP:0000230) | 2.63824826 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.62768356 |
| 58 | Recurrent skin infections (HP:0001581) | 2.61133982 |
| 59 | Pulmonary embolism (HP:0002204) | 2.59892520 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.59566569 |
| 61 | Hyperlipoproteinemia (HP:0010980) | 2.58859007 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.58473755 |
| 63 | Polycythemia (HP:0001901) | 2.58279453 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 2.56656189 |
| 65 | Joint swelling (HP:0001386) | 2.55272061 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54987592 |
| 67 | Glomerulonephritis (HP:0000099) | 2.54148256 |
| 68 | Increased IgE level (HP:0003212) | 2.52068422 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.51928859 |
| 70 | Hemoptysis (HP:0002105) | 2.51592240 |
| 71 | Leukocytosis (HP:0001974) | 2.50933779 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49232202 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.48390582 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.48063945 |
| 75 | Recurrent cutaneous fungal infections (HP:0011370) | 2.48063945 |
| 76 | Abnormality of proline metabolism (HP:0010907) | 2.46272789 |
| 77 | Hydroxyprolinuria (HP:0003080) | 2.46272789 |
| 78 | Anorexia (HP:0002039) | 2.44492682 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.43321914 |
| 80 | Increased serum ferritin (HP:0003281) | 2.42763355 |
| 81 | Chronic otitis media (HP:0000389) | 2.39913406 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.36851499 |
| 83 | Hypochromic anemia (HP:0001931) | 2.36377457 |
| 84 | Hyperglycinuria (HP:0003108) | 2.35134382 |
| 85 | Abnormality of iron homeostasis (HP:0011031) | 2.34375677 |
| 86 | Gangrene (HP:0100758) | 2.33983884 |
| 87 | Cellulitis (HP:0100658) | 2.33577596 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33428237 |
| 89 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33428237 |
| 90 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33428237 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.31295455 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.30804737 |
| 93 | Nephritis (HP:0000123) | 2.30623782 |
| 94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.30204816 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.28489409 |
| 96 | Recurrent fungal infections (HP:0002841) | 2.27031903 |
| 97 | Petechiae (HP:0000967) | 2.24959816 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.24467468 |
| 99 | Bruising susceptibility (HP:0000978) | 2.23079968 |
| 100 | Abnormality of T cells (HP:0002843) | 2.22805724 |
| 101 | Hyperammonemia (HP:0001987) | 2.21896676 |
| 102 | Peritonitis (HP:0002586) | 2.20837445 |
| 103 | Skin nodule (HP:0200036) | 2.19872038 |
| 104 | Epistaxis (HP:0000421) | 2.19055959 |
| 105 | Hemorrhage of the eye (HP:0011885) | 2.17937582 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 2.17140368 |
| 107 | Poikilocytosis (HP:0004447) | 2.15380691 |
| 108 | Increased connective tissue (HP:0009025) | 2.13899154 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13804263 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.13183407 |
| 111 | Vertigo (HP:0002321) | 2.12427801 |
| 112 | Increased IgM level (HP:0003496) | 2.12305168 |
| 113 | Urticaria (HP:0001025) | 2.10565038 |
| 114 | Granulocytopenia (HP:0001913) | 2.10258277 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 2.10149376 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09480840 |
| 117 | Hypolipoproteinemia (HP:0010981) | 2.08680748 |
| 118 | Nausea (HP:0002018) | 2.08524251 |
| 119 | Vasculitis (HP:0002633) | 2.08185774 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 2.08086725 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06876147 |
| 122 | Mucopolysacchariduria (HP:0008155) | 2.06876147 |
| 123 | Conjunctival telangiectasia (HP:0000524) | 2.06773432 |
| 124 | Loss of speech (HP:0002371) | 2.06739897 |
| 125 | Colitis (HP:0002583) | 2.06093344 |
| 126 | Multiple enchondromatosis (HP:0005701) | 2.05533321 |
| 127 | Hypertriglyceridemia (HP:0002155) | 2.04417322 |
| 128 | Osteomyelitis (HP:0002754) | 2.00700974 |
| 129 | Glomerulopathy (HP:0100820) | 1.99914917 |
| 130 | Pustule (HP:0200039) | 1.98845795 |
| 131 | Ketosis (HP:0001946) | 1.98430611 |
| 132 | Hypoglycemic coma (HP:0001325) | 1.97888277 |
| 133 | Upper motor neuron abnormality (HP:0002127) | 1.97376471 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.96220438 |
| 135 | Arthralgia (HP:0002829) | 1.95896478 |
| 136 | Recurrent viral infections (HP:0004429) | 1.95776265 |
| 137 | Abnormality of the pleura (HP:0002103) | 1.95496316 |
| 138 | Basal ganglia calcification (HP:0002135) | 1.95016102 |
| 139 | Acute hepatic failure (HP:0006554) | 1.94629336 |
| 140 | Epidermoid cyst (HP:0200040) | 1.94467474 |
| 141 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94419210 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 1.92847962 |
| 143 | Eosinophilia (HP:0001880) | 1.91347887 |
| 144 | Thrombophlebitis (HP:0004418) | 1.90440464 |
| 145 | Lymphopenia (HP:0001888) | 1.90072276 |
| 146 | Hypochromic microcytic anemia (HP:0004840) | 1.89953504 |
| 147 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89767923 |
| 148 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89767923 |
| 149 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89767923 |
| 150 | Abnormality of glycine metabolism (HP:0010895) | 1.88409431 |
| 151 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88409431 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.86832446 |
| 153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86832446 |
| 154 | Microcytic anemia (HP:0001935) | 1.86218743 |
| 155 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85657179 |
| 156 | Periodontitis (HP:0000704) | 1.85231876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.82627147 |
| 2 | TGFBR2 | 3.43072885 |
| 3 | TYK2 | 3.07240234 |
| 4 | TBK1 | 2.96653457 |
| 5 | FGFR4 | 2.33835277 |
| 6 | KIT | 2.23746407 |
| 7 | TIE1 | 2.11607844 |
| 8 | BLK | 2.11576943 |
| 9 | IKBKE | 2.09955260 |
| 10 | MAP3K14 | 2.08249682 |
| 11 | FES | 2.07176637 |
| 12 | PBK | 2.05480493 |
| 13 | IRAK3 | 2.05202438 |
| 14 | JAK1 | 2.00256756 |
| 15 | CDK12 | 2.00256697 |
| 16 | TNK2 | 1.96818092 |
| 17 | KDR | 1.89815974 |
| 18 | CSF1R | 1.86159584 |
| 19 | JAK3 | 1.85462344 |
| 20 | TRIB3 | 1.80965933 |
| 21 | IKBKB | 1.73789960 |
| 22 | GRK6 | 1.68059833 |
| 23 | TAOK1 | 1.56165967 |
| 24 | PRPF4B | 1.52774047 |
| 25 | BCKDK | 1.52547813 |
| 26 | PIM2 | 1.51060799 |
| 27 | MATK | 1.48560743 |
| 28 | MST1R | 1.46738271 |
| 29 | EPHB1 | 1.46042669 |
| 30 | FGFR3 | 1.44354025 |
| 31 | TAOK2 | 1.43551977 |
| 32 | MAP2K3 | 1.42467137 |
| 33 | TAOK3 | 1.41912182 |
| 34 | MAP4K1 | 1.41187742 |
| 35 | CSK | 1.40844686 |
| 36 | IRAK4 | 1.40584322 |
| 37 | GRK1 | 1.40022367 |
| 38 | STK10 | 1.33976795 |
| 39 | EPHA3 | 1.33201749 |
| 40 | BMPR2 | 1.32809644 |
| 41 | GRK7 | 1.31721988 |
| 42 | GRK5 | 1.30344640 |
| 43 | NEK9 | 1.30226398 |
| 44 | TTN | 1.25734790 |
| 45 | SIK1 | 1.22362582 |
| 46 | JAK2 | 1.21553917 |
| 47 | PTK2B | 1.19371209 |
| 48 | RIPK1 | 1.19126455 |
| 49 | SIK3 | 1.17162152 |
| 50 | ZAP70 | 1.13956712 |
| 51 | RIPK4 | 1.13806336 |
| 52 | MAP3K1 | 1.09289798 |
| 53 | ABL2 | 1.07358905 |
| 54 | MAP3K3 | 1.00698145 |
| 55 | NME2 | 0.98063468 |
| 56 | ADRBK2 | 0.98023898 |
| 57 | CHUK | 0.97322723 |
| 58 | PDK1 | 0.92407822 |
| 59 | TESK2 | 0.90989314 |
| 60 | BMX | 0.89408115 |
| 61 | TEC | 0.88540042 |
| 62 | PRKG2 | 0.85698595 |
| 63 | HCK | 0.85057177 |
| 64 | PTK6 | 0.84109540 |
| 65 | MAP3K10 | 0.83006993 |
| 66 | MOS | 0.82696649 |
| 67 | LRRK2 | 0.81392029 |
| 68 | CAMK1D | 0.81046778 |
| 69 | PKN2 | 0.78779605 |
| 70 | PIK3CG | 0.78431114 |
| 71 | FLT3 | 0.77806826 |
| 72 | ITK | 0.76511515 |
| 73 | TXK | 0.75678266 |
| 74 | YES1 | 0.75489038 |
| 75 | SYK | 0.74484444 |
| 76 | IRAK2 | 0.71960369 |
| 77 | PIM1 | 0.70770179 |
| 78 | BTK | 0.69760498 |
| 79 | MAPK7 | 0.69059098 |
| 80 | MAP3K13 | 0.66996213 |
| 81 | CDC42BPA | 0.65238289 |
| 82 | HIPK2 | 0.63063699 |
| 83 | MAPK12 | 0.63012084 |
| 84 | KSR2 | 0.62780124 |
| 85 | STK4 | 0.62237154 |
| 86 | LCK | 0.60794512 |
| 87 | PAK4 | 0.59877922 |
| 88 | LYN | 0.59104793 |
| 89 | PRKD2 | 0.58832065 |
| 90 | FYN | 0.57754761 |
| 91 | RPS6KA4 | 0.57615042 |
| 92 | MAPK11 | 0.57035478 |
| 93 | CDK6 | 0.55310982 |
| 94 | ACVR1B | 0.55284757 |
| 95 | MARK2 | 0.55221243 |
| 96 | PRKAA2 | 0.54204197 |
| 97 | MYLK | 0.53989420 |
| 98 | MAP3K7 | 0.53106311 |
| 99 | PRKCQ | 0.51981332 |
| 100 | NLK | 0.51727239 |
| 101 | TGFBR1 | 0.51694154 |
| 102 | ABL1 | 0.51168908 |
| 103 | EGFR | 0.51034558 |
| 104 | IGF1R | 0.50603808 |
| 105 | PRKCD | 0.50039504 |
| 106 | RET | 0.49983675 |
| 107 | MAP3K5 | 0.48440605 |
| 108 | CAMK4 | 0.48203210 |
| 109 | MAP3K11 | 0.47697005 |
| 110 | TRPM7 | 0.46447312 |
| 111 | MAPK4 | 0.45518942 |
| 112 | PRKD1 | 0.45064329 |
| 113 | EIF2AK1 | 0.44903566 |
| 114 | DAPK2 | 0.43839904 |
| 115 | SGK3 | 0.43408365 |
| 116 | IRAK1 | 0.42889172 |
| 117 | EIF2AK2 | 0.41828505 |
| 118 | MST4 | 0.41735851 |
| 119 | MAP3K6 | 0.40740908 |
| 120 | PDGFRA | 0.40119385 |
| 121 | DYRK1B | 0.39020627 |
| 122 | INSRR | 0.38140653 |
| 123 | MAPKAPK2 | 0.37245618 |
| 124 | LMTK2 | 0.37016426 |
| 125 | MET | 0.36515483 |
| 126 | MARK3 | 0.36383196 |
| 127 | GSK3A | 0.34386059 |
| 128 | FGR | 0.33710032 |
| 129 | ARAF | 0.33498407 |
| 130 | PDPK1 | 0.33464978 |
| 131 | MAP3K2 | 0.32842466 |
| 132 | RAF1 | 0.31884953 |
| 133 | PAK1 | 0.30978414 |
| 134 | MAP2K6 | 0.29554335 |
| 135 | STK24 | 0.29206911 |
| 136 | SGK2 | 0.28860258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98756734 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62758158 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.53762947 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40275217 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.33308695 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.32427965 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09206113 |
| 8 | Platelet activation_Homo sapiens_hsa04611 | 2.08589510 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06419875 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00435356 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.95248305 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94161728 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.90710182 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84447672 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77079002 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70608499 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69896733 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62897651 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62323686 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61623131 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.59429095 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58242666 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.51744902 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50299588 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48538891 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47984412 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.47507055 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.43707885 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41041190 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.34427641 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33534919 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27147334 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26305605 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24848028 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22985117 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22450005 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20683376 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19720526 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.18635376 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18299422 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.18243982 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16871008 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16516014 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.15080398 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.13917848 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13587754 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.11757426 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10906374 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 1.10508823 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05200220 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.03708371 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03252494 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02334204 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00984102 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99955489 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.98710963 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98236880 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96673488 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96300485 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95900955 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95769115 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94098119 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93108281 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.91201529 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.89807203 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89118052 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88858561 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87839448 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86805939 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86736097 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.86302408 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83100184 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82736245 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80318276 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79983495 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78960456 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.78204883 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78198518 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77877371 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77716994 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77663126 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76875032 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76556433 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76130916 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76108422 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75489554 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75142382 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75103975 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74187021 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74027828 |
| 91 | Phagosome_Homo sapiens_hsa04145 | 0.73918385 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73248197 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.72618019 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.71965173 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69598565 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67731035 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67511351 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.65815350 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65604584 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64854945 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64586369 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64381952 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64107703 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60474817 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59686800 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58780142 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56442631 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56335590 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55964759 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55532084 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55052010 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55039687 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54066464 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.53907328 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53421574 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52964319 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52953374 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52935582 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52931002 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.52000116 |
| 121 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51433444 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49839708 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47089909 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44213862 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44091540 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43198112 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41922525 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41600368 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41582705 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40961562 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40656602 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39970320 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37312567 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36850965 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36433456 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35769981 |
| 137 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35383265 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35226066 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34592132 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34226043 |
| 141 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30697707 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29968367 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29698721 |
| 144 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29638007 |

